Bioinformatic analysis reveals crel as a regulator of a subset of interferon-stimulated genes

Journal of Interferon and Cytokine Research

Volumn 28, Issue 9, 2008, Pages 541-551

  Wei, Lai ^a   Fan, Meiyun ^a   Xu, Lijing ^b,c   Heinrich, Kevin ^d   Berry, Michael W ^d   Homayouni, Ramin ^b,c   Pfeffer, Lawrence M ^a  

^a UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

^b UNIVERSITY OF MEMPHIS   (United States)

^c University of Memphis   (United States)

^d University of Tennessee Knoxville   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARBON CATABOLITE REPRESSOR PROTEIN 1; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERFERON; REPRESSOR PROTEIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; BIOINFORMATICS; CHROMATIN IMMUNOPRECIPITATION; CONTROLLED STUDY; GENE EXPRESSION; GENE SEQUENCE; IMMUNE RESPONSE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN BINDING; PROTEIN MOTIF; PROTEIN PHOSPHORYLATION; SEQUENCE ANALYSIS; SIGNAL TRANSDUCTION;

ANIMALS; CELL LINE; CHROMATIN IMMUNOPRECIPITATION; COMPUTATIONAL BIOLOGY; FIBROBLASTS; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; INTERFERONS; MICE; MICE, INBRED C57BL; PROMOTER REGIONS, GENETIC; PROTO-ONCOGENE PROTEINS C-REL; TRANSCRIPTION FACTOR RELA;

EID: 51349164382     PISSN: 10799907     EISSN: None     Source Type: Journal    
DOI: 10.1089/jir.2007.0136     Document Type: Article

References (49)

1. Arduini RM, Li Z, Rapoza A, Gronke R, Hess DM, Wen D, Miatkowski K, Coots C, Kaffashan A, Viseux N, Delaney J, Domon B, Young CN, Boynton R, Chen LL, Betzenhauser M, Miller S, Gill A, Pepinsky RB, Hochman PS, Baker DP. Expression, purification, and characterization of rat interferon-beta, and preparation of an N-terminally PEGylated form with improved pharmacokinetic parameters. Protein Expr Purif 34(2):229-242.
2. Baker MS, Chen X, Rotramel AR, Nelson JJ, Kaufman DB. 2003. Interferon regulatory factor-1 down-regulates cytokine-induced IP-10 expression in pancreatic islets. Surgery 134(2):134-41.
3. Barnes B, Lubyova B, Pitha PM. 2002. On the role of IRF in host defense. J Interferon Cytokine Res 22(1):59-71.
4. Beg AA, Baltimore D. 1996. An essential role for NF-kB in preventing TNF-a-induced cell death. Science 274:782-784.
5. Beg AA, Sha WC, Bronson RT, Ghosh S, Baltimore D. 1995. Embryonic lethality and liver degeneration in mice lacking the RelA component of NF-kB. Nature 376:167-170.
6. Berry MW, Drmac Z, Jessup E. 1999. Matrices, vector spaces, and information retrieval. SIAM Rev 41:335-362.
7. Bluthgen N, Kielbasa SM, Herzel H. 2005. Inferring combinatorial regulation of transcription in silico. Nucleic Acids Res 33(1):272-279.
8. Bonizzi G, Bebien M, Otero DC, Johnson-Vroom KE, Cao Y, Vu D, Jegga AG, Aronow BJ, Ghosh G, Rickert RC and others. 2004. Activation of IKKalpha target genes depends on recognition of specific kappaB binding sites by RelB:p52 dimers. EMBO J 23(21):4202-4210.
9. Claudio E, Brown K, Park S, Wang H, Siebenlist U. 2002. BAFF-induced NEMO-independent processing of NF-kappa B2 in maturing B cells. Nat Immunol 3(10):958-965.
10. Coope HJ, Atkinson PG, Huhse B, Belich M, Janzen J, Holman MJ, Klaus GG, Johnston LH, Ley SC. 2002. CD40 regulates the processing of NF-kappaB2 p100 to p52. Embo J 21(20):5375-5385.
11. Darnell JEJ, Kerr IM, Stark GR. 1994. Jak-STAT pathways and transcriptional activation in response to IFNs and other extracellular signaling proteins. Science 264:1415-1421.
12. Dejardin E, Droin NM, Delhase M, Haas E, Cao Y, Makris C, Li ZW, Karin M, Ware CF, Green DR. 2002. The lymphotoxin-beta receptor induces different patterns of gene expression via two NF-kappaB pathways. Immunity 17(4):525-535.
13. Friedman RL, Stark GR. 1985. a-Interferon-induced transcription of HLA and metallothionein genes containing homologous upstream sequences. Nature 314:637-639.
14. Gilmore TD, Kalaitzidis D, Liang MC, Starczynowski DT. 2004. The c-Rel transcription factor and B-cell proliferation: a deal with the devil. Oncogene 23(13):2275-2286.
15. Hoffmann A, Leung TH, Baltimore D. 2003. Genetic analysis of NF-kappaB/Rel transcription factors defines functional specificities. EMBO J 22(20):5530-5539.
16. Homayouni R, Heinrich K, Wei L, Berry MW. 2005. Gene clustering by latent semantic indexing of MEDLINE abstracts. Bioinformatics 21(1):104-115.
17. Jenssen TK, Laegreid A, Komorowski J, Hovig E. 2001. A literature network of human genes for high-throughput analysis of gene expression. Nat Genet 28(1):21-28.
18. Kontgen F, Grumont RJ, Strasser A, Metcalf D, Li R, Tarlinton D, Gerondakis S. 1995. Mice lacking the c-rel proto-oncogene exhibit defects in lymphocyte proliferation, humoral immunity, and interleukin-2 expression. Genes Dev 9(16):1965-1977.
19. Krallinger M, Erhardt RA, Valencia A. 2005. Text-mining approaches in molecular biology and biomedicine. Drug Discov Today 10(6):439-445.
20. Kumar A, Yang YL, Flati V, Der S, Kadereit S, Deb A, Haque J, Reis L, Weissmann C, Williams BR. 1997. Deficient cytokine signaling in mouse embryo fibroblasts with a targeted deletion in the PKR gene: role of IRF-1 and NF-kappaB. EMBO J 16(2):406-416.
21. Landauer TK, Laham D, Derr M. 2004. From paragraph to graph: latent semantic analysis for information visualization. Proc Natl Acad Sci USA 101 Suppl 1:5214-5219.
22. Larner AC, Chaudhuri A, Darnell JEJ. 1986. Transcriptional induction by interferon: new protein(s) determine the length and extent of induction. J Biol Chem 261:453-459.
23. Li H, Lu L, Manly KF, Chesler EJ, Bao L, Wang J, Zhou M, Williams RW, Cui Y. 2005. Inferring gene transcriptional modulatory relations: a genetical genomics approach. Hum Mol Genet 14(9):1119-1125.
24. Liou HC, Sha WC, Scott ML, Baltimore D. 1994. Sequential induction of NF-kappa B/Rel family proteins during B-cell terminal differentiation. Mol Cell Biol 14(8):5349-5359.
25. Luftig M, Yasui T, Soni V, Kang MS, Jacobson N, Cahir-McFarland E, Seed B, Kieff E. 2004. Epstein-Barr virus latent infection membrane protein 1 TRAF-binding site induces NIK/IKK alpha-dependent noncanonical NF-kappaB activation. Proc Natl Acad Sci USA 101(1):141-146.
26. Matys V, Fricke E, Geffers R, Gossling E, Haubrock M, Hehl R, Hornischer K, Karas D, Kel AE, Kel-Margoulis OV and others. 2003. TRANSFAC: transcriptional regulation, from patterns to profiles. Nucleic Acids Res 31(1):374-378.
27. Muller JR, Siebenlist U. 2003. Lymphotoxin beta receptor induces sequential activation of distinct NF-kappa B factors via separate signaling pathways. J Biol Chem 278(14):12006-12012.
28. Ohmori Y, Tebo J, Nedospasov S, Hamilton TA. 1994. Kappa B binding activity in a murine macrophage-like cell line. Sequence-specific differences in kappa B binding and transcriptional activation functions. J Biol Chem 269(26):17684-17690.
29. Pfeffer LM, Kim JG, Pfeffer SR, Carrigan DJ, Baker DP, Wei L, Homayouni R. 2004. The role of NF-κB in the antiviral action of interferon and interferon-regulated gene expression. J Biol Chem 279(30):31304-31311.
30. Pomerantz JL, Baltimore D. 2002. Two pathways to NF-kappaB. Mol Cell 10(4):693-695.
31. Qin ZS, McCue LA, Thompson W, Mayerhofer L, Lawrence CE, Liu JS. 2003. Identification of co-regulated genes through Bayesian clustering of predicted regulatory binding sites. Nat Biotechnol 21(4):435-439.
32. Rebholz-Schuhmann D, Kirsch H, Couto F. 2005. Facts from text - is text mining ready to deliver? PLoS Biol 3(2):e65.
33. Schindler C, Fu X-Y, Improta T, Aebersold R, Darnell JEJ. 1992. Proteins of transcription factor ISGF-3: one gene encoded the 91- and 84-kDa ISGF-3 that are activated by interferon a. Proc Natl Acad Sci USA 89:7836-7839.
34. Segal E, Shapira M, Regev A, Pe'er D, Botstein D, Koller D, Friedman N. 2003. Module networks: identifying regulatory modules and their condition-specific regulators from gene expression data. Nat Genet 34(2):166-176.
35. Senftleben U, Cao Y, Xiao G, Greten FR, Krahn G, Bonizzi G, Chen Y, Hu Y, Fong A, Sun SC and others. 2001. Activation by IKKalpha of a second, evolutionary conserved, NF-kappa B signaling pathway. Science 293(5534):1495-1499.
36. Shatkay H, Feldman R. 2003. Mining the biomedical literature in the genomic era: an overview. J Comput Biol 10(6):821-855.
37. Sizemore N, Agarwal A, Das K, Lerner N, Sulak M, Rani S, Ransohoff R, Shultz D, Stark GR. 2004. Inhibitor of kappaB kinase is required to activate a subset of interferon gamma-stimulated genes. Proc Natl Acad Sci USA 101(21):7994-7998.
38. Van Antwerp DJ, Martin SJ, Kafri T, Green DR, Verma IM. 1996. Suppression of TNF-a-induced apotosis by NF-kB. Science 274:787-789.
39. Wang C-Y, Mayo MW, Baldwin Jr. AS. 1996. TNF- and cancer therapy-induced apoptosis: potentiation by inhibition of NF-kB. Science 274:784-787.
40. Wei L, Sandbulte MR, Thomas PG, Webby RJ, Homayouni R, Pfeffer LM. 2006. NF?B negatively regulates interferon-induced gene expression and anti-influenza activity. J Biol Chem 281(17):11678-11684.
41. Xiao G, Fong A, Sun SC. 2004. Induction of p100 processing by NF-kappaB-inducing kinase involves docking IkappaB kinase alpha (IKKalpha) to p100 and IKKalpha-mediated phosphorylation. J Biol Chem 279(29):30099-30105.
42. Xiao G, Harhaj EW, Sun SC. 2001. NF-kappaB-inducing kinase regulates the processing of NF-kappaB2 p100. Mol Cell 7(2):401-409.
43. Xie X, Lu J, Kulbokas EJ, Golub TR, Mootha V, Lindblad-Toh K, Lander ES, Kellis M. 2005. Systematic discovery of regulatory motifs in human promoters and 3' UTRs by comparison of several mammals. Nature 434(7031):338-345.
44. Yandell MD, Majoros WH. 2002. Genomics and natural language processing. Nat Rev Genet 3(8):601-610.
45. Yang CH, Murti A, Basu L, Kim JG, Pfeffer LM. 2000. IFNα/β promotes cell survival by activating NF-κB. Proc Natl Acad Sci USA 97:13631-13636.
46. Yang CH, Murti A, Pfeffer SR, Kim JG, Donner DB, Pfeffer LM. 2001. Interferon α/β promotes cell survival by activating NF-κB through phosphatidylinositol-3 kinase and Akt. J Biol Chem 276:13756-13761.
47. Yang CH, Murti A, Pfeffer LM. 2005a. IFN induces NIK/TRAF dependent NF-κB activation to promote cell survival. J Biol Chem 280(36):31530-31536.
48. Yang CH, Murti A, Valentine WJ, Du Z, Pfeffer LM. 2005b. Interferon alpha activates NF-κB in JAK1-deficient cells through a TYK2-dependent pathway. J Biol Chem 280(27):25849-25853.
49. Yang CH, Wei L, Pfeffer SR, Du Z, Murti A, Valentine WJ, Zheng Y, Pfeffer LM. 2007. Identification of CXCL11 as a STAT3-dependent gene induced by IFN. J Immunol 178(2):986-992.